In this podcast, Motley Fool contributor Brian Orelli interviews Anne Wojcicki, the CEO of 23andMe (ME -3.55%), about her company and why it's looking to tell you much more than the names of your long-lost relatives.
They discuss:
Opportunities in direct-to-consumer healthcare.
Creating more personalized medicine.
The limits of genetic testing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,